Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol for Endometriosis-Associated Pain
NCT00758953Phase 2
Key facts
- Status
- Completed
- Start
- Feb 2007
- Primary completion
- Jan 2009
- Countries
- 3
- Sponsor
- Lumara Health
- Modality
- Orthosteric Ligands
- Drugs
- danazol
- Conditions
- endometriosis
01
Overview
Phase 2, randomised, double-blind trial of danazol in endometriosis (4 arms), sponsored by Lumara Health. Primary endpoint: Pain associated with endometriosis at 3 months. Started Feb 2007; status: completed.
02
Design
4 arms- Study design
- RandomizedDouble-blind
Danazol Once Weekly
Experimental arm receiving semi-solid danazol once per week
Danazol Twice Weekly
Experimental arm receiving semi-solid danazol twice per week
Placebo Once Weekly
Control arm receiving semi-solid placebo once per week
Placebo Twice Weekly
Control arm receiving semi-solid placebo twice per week
03
Endpoints
Primary
Pain associated with endometriosis
Beyond the preview
Go deeper on NCT00758953.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758953.